A.A.PottegårdA.A. i inni, Hydrochlorothiazide use is strongly associated with risk of lip cancer, „Journal of Internal Medicine”, 282 (4), 2017, s. 322–331, DOI: 10.1111/joim.12629, PMID: 28480532(ang.).
Sidsel ArnspangS.A.PedersenSidsel ArnspangS.A. i inni, Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark, „Journal of the American Academy of Dermatology”, 78 (4), 2018, 673–681.e9, DOI: 10.1016/j.jaad.2017.11.042, PMID: 29217346(ang.).
inchem.org
Rosane MariaR.M.SalviRosane MariaR.M., Hydrochlorothiazide [online], International Programme on Chemical Safety INCHEM, 1992 [dostęp 2018-10-22](ang.).
nih.gov
ncbi.nlm.nih.gov
A.A.PottegårdA.A. i inni, Hydrochlorothiazide use is strongly associated with risk of lip cancer, „Journal of Internal Medicine”, 282 (4), 2017, s. 322–331, DOI: 10.1111/joim.12629, PMID: 28480532(ang.).
Sidsel ArnspangS.A.PedersenSidsel ArnspangS.A. i inni, Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark, „Journal of the American Academy of Dermatology”, 78 (4), 2018, 673–681.e9, DOI: 10.1016/j.jaad.2017.11.042, PMID: 29217346(ang.).